Culture Conditions for Mycelial Growth and Anti-Cancer Properties of .

Suphachai Tharavecharak, Corina N D'Alessandro-Gabazza, Masaaki Toda, Taro Yasuma, Taku Tsuyama, Ichiro Kamei, Esteban C Gabazza
Author Information
  1. Suphachai Tharavecharak: Graduate School of Agriculture, University of Miyazaki, Miyazaki, Japan.
  2. Corina N D'Alessandro-Gabazza: Department of Immunology, Faculty of Medicine, Graduate School of Medicine, Mie University, Tsu, Japan.
  3. Masaaki Toda: Department of Immunology, Faculty of Medicine, Graduate School of Medicine, Mie University, Tsu, Japan.
  4. Taro Yasuma: Department of Immunology, Faculty of Medicine, Graduate School of Medicine, Mie University, Tsu, Japan.
  5. Taku Tsuyama: Graduate School of Agriculture, University of Miyazaki, Miyazaki, Japan.
  6. Ichiro Kamei: Graduate School of Agriculture, University of Miyazaki, Miyazaki, Japan.
  7. Esteban C Gabazza: Department of Immunology, Faculty of Medicine, Graduate School of Medicine, Mie University, Tsu, Japan. ORCID

Abstract

sp. that grow in symbiosis with fungus-farming Termites have medicinal properties. However, they are rare in nature, and their artificial culture is challenging. The expression of AXL receptor tyrosine kinase and immune checkpoint molecules favor the growth of cancer cells. The study evaluated the optimal conditions for the artificial culture of and their inhibitory activity on AXL and immune checkpoint molecules in lung adenocarcinoma and melanoma cell lines. The culture of 45 strains of was compared. Five strains with marked growth rates were selected. Four of the selected strains form a single cluster by sequence analysis. The mycelium of 4 selected strains produces more fungal mass in potato dextrose broth than in a mixed media. The bark was the most appropriate solid substrate for mycelia culture. The mycelium of all five selected strains showed a higher growth rate under normal CO conditions. The culture broth, methanol, and ethyl acetate of one selected strain (T-120) inhibited the mRNA relative expression of AXL receptor tyrosine kinase and immune checkpoint molecules in cancer cell lines. Overall, these results suggest the potential usefulness of extracts as a co-adjuvant therapy in malignant diseases.

Keywords

References

  1. Sci Adv. 2019 Mar 22;5(3):eaat8520 [PMID: 30915392]
  2. Int J Biol Macromol. 2016 Oct;91:198-207 [PMID: 27180294]
  3. Springerplus. 2015 Aug 20;4:433 [PMID: 26306295]
  4. Insects. 2019 Mar 28;10(4): [PMID: 30925664]
  5. Cell Mol Life Sci. 2021 Mar;78(6):2749-2769 [PMID: 33388854]
  6. J Agric Food Chem. 2002 Oct 9;50(21):6072-7 [PMID: 12358482]
  7. Pharm Biol. 2016 Nov;54(11):2536-2546 [PMID: 27225970]
  8. J Agric Food Chem. 2001 Nov;49(11):5461-7 [PMID: 11714344]
  9. J Ethnopharmacol. 2008 Dec 8;120(3):432-6 [PMID: 18948177]
  10. J Basic Clin Physiol Pharmacol. 2018 Nov 27;29(6):645-650 [PMID: 30091949]
  11. Physiol Biochem Zool. 2001 Nov-Dec;74(6):798-822 [PMID: 11731972]
  12. 3 Biotech. 2012 Mar;2(1):1-15 [PMID: 22582152]
  13. Mycol Res. 2003 Nov;107(Pt 11):1277-86 [PMID: 15000230]
  14. Biomed Pharmacother. 2021 Nov;143:112106 [PMID: 34482165]
  15. Bioengineered. 2021 Dec;12(2):11239-11268 [PMID: 34738876]
  16. Proc Natl Acad Sci U S A. 2015 Sep 15;112(37):11589-93 [PMID: 26316023]
  17. Biosci Biotechnol Biochem. 2020 Jul;84(7):1332-1338 [PMID: 32200702]
  18. J Insect Sci. 2011;11:122 [PMID: 22224433]
  19. J Clin Med Res. 2015 Feb;7(2):76-82 [PMID: 25436023]
  20. Insects. 2020 Aug 13;11(8): [PMID: 32823564]
  21. Biosci Biotechnol Biochem. 2002 May;66(5):1159-63 [PMID: 12092837]
  22. Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):14887-92 [PMID: 12386341]
  23. Appl Microbiol Biotechnol. 2018 Jun;102(12):4987-4994 [PMID: 29704040]
  24. Curr Med Chem. 2009;16(12):1543-60 [PMID: 19355906]
  25. Adv Nutr. 2021 Oct 1;12(5):1691-1704 [PMID: 33724299]
  26. Int J Med Mushrooms. 2019;21(6):571-582 [PMID: 31679229]
  27. J Ethnopharmacol. 2007 Mar 1;110(1):160-4 [PMID: 17092673]
  28. Anticancer Agents Med Chem. 2010 Jun;10(5):424-36 [PMID: 20545620]
  29. FEBS J. 2006 Dec;273(23):5231-44 [PMID: 17064312]
  30. Appl Microbiol Biotechnol. 2006 Nov;73(1):195-203 [PMID: 17021881]
  31. Appl Biochem Biotechnol. 2020 Dec;192(4):1270-1283 [PMID: 32720080]
  32. Nat Commun. 2020 Mar 24;11(1):1539 [PMID: 32210242]
  33. Cells. 2022 Jan 22;11(3): [PMID: 35159184]
  34. Cancers (Basel). 2016 Nov 29;8(12): [PMID: 27916840]
  35. J Antibiot (Tokyo). 2020 Oct;73(10):733-736 [PMID: 32457442]
  36. Nat Rev Immunol. 2020 Nov;20(11):651-668 [PMID: 32433532]
  37. Carbohydr Polym. 2015 Dec 10;134:375-84 [PMID: 26428137]
  38. J Agric Food Chem. 2022 Jan 12;70(1):21-33 [PMID: 34936332]
  39. Curr Biol. 2005 May 10;15(9):851-5 [PMID: 15886104]
  40. J Fungi (Basel). 2021 Jul 23;7(8): [PMID: 34436128]
  41. Mutat Res. 2001 Sep 20;496(1-2):15-21 [PMID: 11551476]
  42. Food Chem. 2014 Aug 15;157:30-6 [PMID: 24679748]
  43. J Exp Biol. 2017 Sep 15;220(Pt 18):3260-3269 [PMID: 28931718]
  44. Bot Stud. 2017 Sep 19;58(1):39 [PMID: 28929370]
  45. Nat Commun. 2022 Mar 23;13(1):1558 [PMID: 35322016]

Word Cloud

Created with Highcharts 10.0.0culturestrainsselectedAXLartificialimmunecheckpointmoleculesgrowthexpressionreceptortyrosinekinasecancerconditionscelllinesmyceliumbrothspgrowsymbiosisfungus-farmingTermitesmedicinalpropertiesHoweverrarenaturechallengingfavorcellsstudyevaluatedoptimalinhibitoryactivitylungadenocarcinomamelanoma45comparedFivemarkedratesFourformsingleclustersequenceanalysis4producesfungalmasspotatodextrosemixedmediabarkappropriatesolidsubstratemyceliafiveshowedhigherratenormalCOmethanolethylacetateonestrainT-120inhibitedmRNArelativeOverallresultssuggestpotentialusefulnessextractsco-adjuvanttherapymalignantdiseasesCultureConditionsMycelialGrowthAnti-CancerPropertiesEdiblemushroomPD-L1PD-L2Termitomyces

Similar Articles

Cited By (1)